What exactly did UBS change in its ACN analyst rating on March 17, 2026?

UBS made no change to the rating format; it **maintained a Buy** on Accenture plc (ACN) on March 17, 2026. UBS did not issue a new price target, so the note reaffirmed prior expectations rather than altering valuation guidance.

How should investors interpret a maintained ACN analyst rating?

A maintained **ACN analyst rating** means the analyst still prefers the stock versus peers. It signals steady confidence but lacks fresh upside from a new price target, so investors should combine this with financials and guidance for action.

Did UBS provide a new ACN price target with the reiteration?

No. The UBS note on March 17, 2026 did not include a new **ACN price target**. Investors must therefore rely on existing targets, company guidance, and Meyka AI analysis for valuation context.

How does Meyka AI’s grade interact with analyst ratings like UBS’s?

Meyka AI rates **ACN with a grade of A**, reflecting benchmark, sector, growth, metrics, and consensus. The UBS maintained Buy aligns with that grade but the Meyka score is a model output, not personalized advice.

Analyst Ratings

UBS Maintains Buy on Accenture plc (ACN) March 17, 2026

ByHuzaifa Zahoor March 18, 2026

UBS maintained a Buy rating on Accenture plc (ACN) on March 17, 2026, reaffirming confidence in the company’s consulting and cloud services momentum. The UBS note did not change the rating but cited steady demand trends and strategic client wins. The ACN analyst rating stay coincided with a modest share move of -0.29% (−$0.57) following the release. Investors should view this as an endorsement of Accenture’s strategy rather than a new bullish catalyst, given there was no fresh price target in the UBS communication.